Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 6,141m
  • Volume: 0
  • RiskGrade: 268

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-24 Interim 34.03 (11.36) (0.23)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 78.20 8.07 1.11p 12.6 0.1 +102% n/a 0.0%
30-Jun-21 84.33 3.66 0.45p 55.6 n/a -60% n/a 0.0%
30-Jun-22 72.77 (12.66) (2.14)p n/a n/a n/a n/a 0.0%
30-Jun-23 59.59 (41.77) (6.43)p n/a n/a n/a n/a 0.0%
30-Jun-24 55.20 (39.17) (1.07)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 55.00 (26.00) (0.72)p n/a n/a n/a n/a 0.0%
30-Jun-26 77.00 (13.50) (0.47)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 12.61 n/a 10.68 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AGY Market Data

Currency UK Pounds
Share Price 8.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 6,141m
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

AGY Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AGY Key Personnel

CEO Manuel Llobet

Top of Page